Mosunetuzumab for CLL MRD Clearance
Conditions
- Leukemia
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Lymphoma
Interventions
- DRUG: Mosunetuzumab
- DRUG: Ibrutinib
- DRUG: Acalabrutinib
- DRUG: Zanubrutinib
- DRUG: Pirtobrutinib
Sponsor
Inhye Ahn
Collaborators